This trial is conducted in Europe and Asia. The aim of this trial is to evaluate the clinical efficacy of a single dose of NNC 0142-0000-0002 administered to subjects with active rheumatoid arthritis (RA).
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01181050?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
